Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked ...

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.

Dexcom, the local maker of continuous glucose monitors, received a warning letter from the Food and Drug Administration last ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Non-Invasive Blood Glucose Monitoring Devices Market was valued US$ 24.3 Mn in 2025 and is expected to reach US$ 68.3 Mn by 2032 growing at a CAGR of 15.9%. BURLINGAME, CA, UNITED STATES ...

DexCom Option Volume And Open Interest Over ... CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide ...